Terms: = Gastric cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Prognosis
10 results:
1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
Shimozaki K; Shinozaki E; Yamamoto N; Imamura Y; Osumi H; Nakayama I; Wakatsuki T; Ooki A; Takahari D; Ogura M; Chin K; Watanabe M; Yamaguchi K
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1273-1283. PubMed ID: 35438321
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer.
Wang G; He Y; Sun Y; Wang W; Qian X; Yu X; Pan Y
Clin Transl Oncol; 2020 Jun; 22(6):813-822. PubMed ID: 31587152
[TBL] [Abstract] [Full Text] [Related]
4. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better prognosis in Intraductal Pancreatic Mucinous Neoplasms.
Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J
Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231
[TBL] [Abstract] [Full Text] [Related]
5. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the nras/MEK1/ERK1/2 signaling.
Zhang J; Hou L; Liang R; Chen X; Zhang R; Chen W; Zhu J
Mol Cancer; 2019 Apr; 18(1):80. PubMed ID: 30953514
[TBL] [Abstract] [Full Text] [Related]
6. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and prognosis of Colorectal cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract] [Full Text] [Related]
7. Translating genomic profiling to gastrointestinal cancer treatment.
Harada K; Mizrak Kaya D; Shimodaira Y; Song S; Baba H; Ajani JA
Future Oncol; 2017 Apr; 13(10):919-934. PubMed ID: 28067073
[TBL] [Abstract] [Full Text] [Related]
8. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and nras mutations in advanced gastric cancer.
Takahashi N; Yamada Y; Taniguchi H; Fukahori M; Sasaki Y; Shoji H; Honma Y; Iwasa S; Takashima A; Kato K; Hamaguchi T; Shimada Y
BMC Res Notes; 2014 Apr; 7():271. PubMed ID: 24774510
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine.
Warneke VS; Behrens HM; Haag J; Balschun K; Böger C; Becker T; Ebert MP; Lordick F; Röcken C
Diagn Mol Pathol; 2013 Sep; 22(3):127-37. PubMed ID: 23846438
[TBL] [Abstract] [Full Text] [Related]
